Clobutinol

CHEMBL1474889 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
255.8 g/mol
LogP
3.2
Phase
4

Withdrawal from the market, rather than current practice, defines the status of clobutinol. The compound acted centrally on the cough centre to suppress cough and was for a period available without prescription in several countries. Reports of serious cardiac rhythm disturbance led to its removal from those markets, and it is no longer in therapeutic use. The case is cited as an example of an over-the-counter antitussive withdrawn on cardiac safety grounds after wide exposure in the general population. Structurally it is a small molecule with the formula C14H22ClNO and a molecular weight near 255.8 g/mol. Its recorded development reached the final clinical phase before the safety signal emerged.

An antitussive medication that was used to suppress coughs by acting on the cough center in the brain. It was once available over the counter in several countries but was withdrawn from markets due to concerns about serious heart rhythm disturbances. It should no longer be used.

Khối lượng phân tử

255,7800 g/mol

LogP

3,20

TPSA

23,50 Ų

Lipinski RO5

Đạt

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1

InChI

InChI=1S/C14H22ClNO/c1-11(10-16(3)4)14(2,17)9-12-5-7-13(15)8-6-12/h5-8,11,17H,9-10H2,1-4H3

Molecular Formula

C14H22ClNO

HBD / HBA

1 / 2

Liên kết có thể quay

5

Nguyên tử nặng

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

An antitussive medication that was used to suppress coughs by acting on the cough center in the brain. It was once available over the counter in several countries but was withdrawn from markets due to concerns about serious heart rhythm disturbances. It should no longer be used.

Yes, Clobutinol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1474889. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 26937. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.